Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Business Mint awarded Seema Thomas as the Most Prominent Women Creative Marketer – 2022 Business
  • Archtrix to be a game changer for architects and interior designers in Surat Lifestyle
  • Kingston Returns to COMPUTEX 2023 with New Non-Binary DDR5 Memory and XS1000 External SSD Technology
  • Atharv Jewels Expands 14-Carat Gold Jewellery Portfolio Under Founder Ritika Agarwal Business
  • Dr. Vivek Lolage bags Atma-Nirbhar Bharat Conclave & Awards 2022 for his remarkable contribution to proctology Lifestyle
  • PVL 2025 Season 4 (Match 37): Bengaluru Torpedoes overpower Ahmedabad Defenders to seal Final berth against Mumbai Meteors Sports
  • Dr. Sanjay N, A Platinum Elite Invisalign Provider, Helps Patients Tackle Dental Issues With Invisible Braces Health
  • Digital transformation company Appinventiv unlocks the hidden IT potential of enterprises English

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Dr. Prakhyat Roop: A Visionary in Refractive Surgery Innovations Health
  • Concept Medical’s 3-Year SIRONA Data Brings Long-Term Outcomes Back Into the Conversation Health
  • Psychotherapist Namrata Jain Sounds the Alarm Bells for India’s Silent but Escalating Self-Harm Epidemic Health
  • The husband-and-wife duo built a complete health solution to fight micronutrient deficiency in India Health
  • Dentium to host the World’s Largest Dental Seminar in Delhi  on 21st April 2024 Health
  • Sreekanth Erepalli: Pioneering Tradition and Innovation in field of Ayurveda and Herbal Cosmetics Health

Recent Posts

  • Hettich Brings Its Magical Experience to Solapur with a New Hettich Exclusive (HeX) Store Launch
  • The Power of Cranberries: A Natural Boost for Gut Microbiome Health
  • Fabtech Technologies Cleanrooms Limited Crosses Rs 200 Crore in Revenue, PAT Grows 18.95% in FY2026
  • KRM Ayurveda Limited Crosses JPY 100+ Crore Revenue Milestone in FY26;H2 FY26 EBITDA Grows ~100% YoY and PAT Surges ~149%, with PAT MarginsNearly Doubling
  • Konkana Bakshi Trains Pageant Winners on Etiquette and Image Building

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Leading Utility Token YES WORLD seen significant adoption, reaches milestone of 1.5 million transactions Business
  • Akanksha Kanwal Shukla’s Elegance Embrace: Beatitude’s Voyage to International Splendor Business
  • 1200 Students of CBitss Artificial Intelligence Program Secure Placements with Packages Ranging from INR 10–15 Lakh per Annum. Education
  • 10 Best Dentists Debunk Common Myths About Dental Implants Business
  • Kolkata Celebrates Swami Vivekananda’s 162nd Birth Anniversary with Grandeur Lifestyle
  • Narayana Schools Launches Heartfelt Campaign: “Parents Inspire Us to Do Our Best – Your Dreams Are Our Dreams” Education
  • Jamboree Education Turns 32: Celebrating Dreams and Global Careers Education
  • Zootopia 2 box office record Signals a Turning Point for Animated Cinema Entertainment

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme